Argus

•

May 14, 2026

Symbols

Sector(s)

Healthcare

Rating

Earnings Estimate

Current Price

$396.71

Price Target

Summary

Elevance is a health benefits company. It operates through two segments: Health Benefits and Carelon Services. The Health Benefits segment provides insurance to members to individuals, employer groups, Medicaid, Medicare Advantage, and the federal sector. Carelon is composed of Carelon Rx, which provides prescription management services, and Carelon Services. The services include medical benefit and behaviora

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

David H. Toung

Senior Analyst: Medical Devices & Healthcare Services

David covers the Pharmaceutical, Medical Devices, and Healthcare services sectors for Argus. He has more than two decades of experience in the financial analysis industry, having worked for McDonald & Co., JPMorgan Chase and Standard & Poor's, among others. His commentary has appeared on CNBC and in The New York Times. Prior to his financial career, David was a private practice attorney in New Jersey, and served as a Judicial Clerk for an Appellate Division judge in the New Jersey Superior Court. David has a law degree from Rutgers University, where he was a member of the Law Review. He has a B.A. degree in Government from Cornell University. He has passed Level II of the Chartered Financial Analyst examination.

Sign in to access your portfolio